Notably, no association with OS was observed when investigating the overall cohort or when restricting to ABC classified patients, supporting that altered NOTCH3 −exon 16 transcript expression has a different impact depending on molecular subtypes of DLBCL. This evidence concerns the gene NOTCH3 and diffuse large B-cell lymphoma.